FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898662364> ?p ?o ?g. }

• W2898662364 endingPage "257" @default.
• W2898662364 startingPage "248" @default.
• W2898662364 abstract "ObjectivesEnd stage renal disease (ESRD) patients with peripheral arterial disease (PAD) are at high risk of complications following open surgical revascularisation (OSR). Endovascular revascularisation (ER) is an option, but its role is unclear. This study sought to characterise the outcomes of ER and OSR in ESRD patients treated for claudication or critical limb ischaemia (CLI).MethodsThe United States Renal Data System was used to investigate outcomes after lower extremity ER and OSR from 2005 to 2011. Primary outcomes were mortality, amputation, and peri-procedural myocardial infarction (MI). Kaplan-Meier (K-M) estimates were generated for mortality and amputation, logistic regression models for 30 day predictors, and proportional hazards models for long-term predictors.ResultsA total of 20,347 patients underwent OSR and ER (20.3% OSR, 79.7% ER). CLI was the indication in 80.8% of ER and 88.4% of OSR. The unadjusted major amputation rate at 30 days was higher after ER compared with OSR (8.8% vs. 6.4%, p < .001). Conversely, the unadjusted mortality rate at 30 days was lower after ER compared with OSR (8.0% vs. 10.5%, p < .001). Multivariable logistic regression models adjusting for medical covariables and CLI versus claudication status demonstrated increased 30 day mortality risk with OSR compared with ER (OR 2.00, 95% CI 1.43–1.79, p < .001), MI (OR 1.38, 1.23–1.54, p < .001), and the combined endpoint of mortality and major amputation (OR 1.57, 1.16–2.12, p = .004), but lower odds of 30 day major amputation alone (OR 0.67, 0.58–0.77, p < .001). Proportional hazards models demonstrated increased long-term mortality risk with OSR compared with ER (HR 1.05, 1.00–1.09, p = .037), without a difference in major amputation (HR 0.99, 0.93–1.05, p = NS).ConclusionsIn this retrospective analysis of an administrative database, ESRD patients suffer from high mortality and amputation rates following lower extremity revascularisation. Compared with ER, OSR is associated with higher mortality. OSR has better 30 day limb salvage, although long-term outcomes are similar. End stage renal disease (ESRD) patients with peripheral arterial disease (PAD) are at high risk of complications following open surgical revascularisation (OSR). Endovascular revascularisation (ER) is an option, but its role is unclear. This study sought to characterise the outcomes of ER and OSR in ESRD patients treated for claudication or critical limb ischaemia (CLI). The United States Renal Data System was used to investigate outcomes after lower extremity ER and OSR from 2005 to 2011. Primary outcomes were mortality, amputation, and peri-procedural myocardial infarction (MI). Kaplan-Meier (K-M) estimates were generated for mortality and amputation, logistic regression models for 30 day predictors, and proportional hazards models for long-term predictors. A total of 20,347 patients underwent OSR and ER (20.3% OSR, 79.7% ER). CLI was the indication in 80.8% of ER and 88.4% of OSR. The unadjusted major amputation rate at 30 days was higher after ER compared with OSR (8.8% vs. 6.4%, p < .001). Conversely, the unadjusted mortality rate at 30 days was lower after ER compared with OSR (8.0% vs. 10.5%, p < .001). Multivariable logistic regression models adjusting for medical covariables and CLI versus claudication status demonstrated increased 30 day mortality risk with OSR compared with ER (OR 2.00, 95% CI 1.43–1.79, p < .001), MI (OR 1.38, 1.23–1.54, p < .001), and the combined endpoint of mortality and major amputation (OR 1.57, 1.16–2.12, p = .004), but lower odds of 30 day major amputation alone (OR 0.67, 0.58–0.77, p < .001). Proportional hazards models demonstrated increased long-term mortality risk with OSR compared with ER (HR 1.05, 1.00–1.09, p = .037), without a difference in major amputation (HR 0.99, 0.93–1.05, p = NS). In this retrospective analysis of an administrative database, ESRD patients suffer from high mortality and amputation rates following lower extremity revascularisation. Compared with ER, OSR is associated with higher mortality. OSR has better 30 day limb salvage, although long-term outcomes are similar." @default.
• W2898662364 created "2018-11-09" @default.
• W2898662364 creator A5000967544 @default.
• W2898662364 creator A5003821131 @default.
• W2898662364 creator A5021911875 @default.
• W2898662364 creator A5039147795 @default.
• W2898662364 creator A5055061698 @default.
• W2898662364 creator A5058636986 @default.
• W2898662364 creator A5067165339 @default.
• W2898662364 creator A5072920508 @default.
• W2898662364 date "2019-02-01" @default.
• W2898662364 modified "2023-10-18" @default.
• W2898662364 title "Editor's Choice – Comparison of Outcomes After Open Surgical and Endovascular Lower Extremity Revascularisation Among End Stage Renal Disease Patients on Dialysis" @default.
• W2898662364 cites W1565785251 @default.
• W2898662364 cites W1968845564 @default.
• W2898662364 cites W1971622042 @default.
• W2898662364 cites W1975648617 @default.
• W2898662364 cites W1978925763 @default.
• W2898662364 cites W2006462482 @default.
• W2898662364 cites W2013857545 @default.
• W2898662364 cites W2027622788 @default.
• W2898662364 cites W2045354183 @default.
• W2898662364 cites W2049760640 @default.
• W2898662364 cites W2081806629 @default.
• W2898662364 cites W2113350075 @default.
• W2898662364 cites W2125829260 @default.
• W2898662364 cites W2126786332 @default.
• W2898662364 cites W2128637012 @default.
• W2898662364 cites W2129162902 @default.
• W2898662364 cites W2138657762 @default.
• W2898662364 cites W2144985796 @default.
• W2898662364 cites W2145600607 @default.
• W2898662364 cites W2155730805 @default.
• W2898662364 cites W2158021861 @default.
• W2898662364 cites W2185467918 @default.
• W2898662364 cites W2465379097 @default.
• W2898662364 cites W2604567203 @default.
• W2898662364 cites W2745103942 @default.
• W2898662364 cites W2975859535 @default.
• W2898662364 cites W4289886312 @default.
• W2898662364 cites W75386920 @default.
• W2898662364 cites W2046940312 @default.
• W2898662364 doi "https://doi.org/10.1016/j.ejvs.2018.09.008" @default.
• W2898662364 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6397783" @default.
• W2898662364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30385187" @default.
• W2898662364 hasPublicationYear "2019" @default.
• W2898662364 type Work @default.
• W2898662364 sameAs 2898662364 @default.
• W2898662364 citedByCount "8" @default.
• W2898662364 countsByYear W28986623642020 @default.
• W2898662364 countsByYear W28986623642021 @default.
• W2898662364 crossrefType "journal-article" @default.
• W2898662364 hasAuthorship W2898662364A5000967544 @default.
• W2898662364 hasAuthorship W2898662364A5003821131 @default.
• W2898662364 hasAuthorship W2898662364A5021911875 @default.
• W2898662364 hasAuthorship W2898662364A5039147795 @default.
• W2898662364 hasAuthorship W2898662364A5055061698 @default.
• W2898662364 hasAuthorship W2898662364A5058636986 @default.
• W2898662364 hasAuthorship W2898662364A5067165339 @default.
• W2898662364 hasAuthorship W2898662364A5072920508 @default.
• W2898662364 hasBestOaLocation W28986623641 @default.
• W2898662364 hasConcept C126322002 @default.
• W2898662364 hasConcept C141071460 @default.
• W2898662364 hasConcept C151956035 @default.
• W2898662364 hasConcept C156957248 @default.
• W2898662364 hasConcept C2776204877 @default.
• W2898662364 hasConcept C2777466421 @default.
• W2898662364 hasConcept C2778063415 @default.
• W2898662364 hasConcept C2778963770 @default.
• W2898662364 hasConcept C2779464278 @default.
• W2898662364 hasConcept C2779881954 @default.
• W2898662364 hasConcept C2779978075 @default.
• W2898662364 hasConcept C2781099653 @default.
• W2898662364 hasConcept C3018348675 @default.
• W2898662364 hasConcept C3019040382 @default.
• W2898662364 hasConcept C500558357 @default.
• W2898662364 hasConcept C50382708 @default.
• W2898662364 hasConcept C71924100 @default.
• W2898662364 hasConceptScore W2898662364C126322002 @default.
• W2898662364 hasConceptScore W2898662364C141071460 @default.
• W2898662364 hasConceptScore W2898662364C151956035 @default.
• W2898662364 hasConceptScore W2898662364C156957248 @default.
• W2898662364 hasConceptScore W2898662364C2776204877 @default.
• W2898662364 hasConceptScore W2898662364C2777466421 @default.
• W2898662364 hasConceptScore W2898662364C2778063415 @default.
• W2898662364 hasConceptScore W2898662364C2778963770 @default.
• W2898662364 hasConceptScore W2898662364C2779464278 @default.
• W2898662364 hasConceptScore W2898662364C2779881954 @default.
• W2898662364 hasConceptScore W2898662364C2779978075 @default.
• W2898662364 hasConceptScore W2898662364C2781099653 @default.
• W2898662364 hasConceptScore W2898662364C3018348675 @default.
• W2898662364 hasConceptScore W2898662364C3019040382 @default.
• W2898662364 hasConceptScore W2898662364C500558357 @default.
• W2898662364 hasConceptScore W2898662364C50382708 @default.
• W2898662364 hasConceptScore W2898662364C71924100 @default.
• W2898662364 hasFunder F4320332161 @default.
• W2898662364 hasIssue "2" @default.
• W2898662364 hasLocation W28986623641 @default.

• next